We wake up each morning excited about helping our customers and partners bring medicines closer to human use. The joy of working in an innovation-rich, research-powered startup bridging multiple disciplines drives us. With each of our special skills from different disciplines, we can make a tremendous impact!
In silico solutions, deep chemistry, computational biology, omics, and high throughput science solutions, for example, are transforming the biopharma industry. Our cross-domain team of experts works with proprietary and open platforms to embark upon and industrialize this transformation.
What do we do?
Examples of our work
Why is our work important?
The Discovery and development of drugs today are dramatically different from a decade ago. From small molecules and early biologicals, medicines have evolved to mAbs (monoclonal antibodies), ADCs (antibody-drug conjugates), targeted cells, genes, and advanced therapies that use viral and non-viral nanotechnologies as delivery vectors. The mechanisms of action are increasingly diverse with explosive innovation driving them. Research has also progressed from a single drug to platform solutions.
Most importantly, today’s pipelines for bringing medicines to market from discovery to delivery require a strong cross-disciplinary approach bridging Chemistry, Biology, and Advanced Computing/Informatics. We have assembled team members and leaders from different disciplines to play a key role in this transformation.
We bring platform approaches to molecular medicine powered by machine learning, AI, omics, and big data. Discovery and delivery of new therapeutics in these novel ways are at the core of what we do at Aganitha.